Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Apollo Endosurgery Inc.

    NASDAQ: APEN · Real-Time Price · USD
    10.00
    0.00 (0.00%)
    At close: Apr 03, 2023, 10:00 PM

    Apollo Endosurgery Statistics

    Share Statistics

    Apollo Endosurgery has 57.97M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 57.97M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 39.54M

    Failed to Deliver (FTD) Shares

    n/a
    		 760

    FTD / Avg. Volume

    n/a
    		 0.06%

    Short Selling Information

    The latest short interest is 375.92K, so 0% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 375.92K

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -10.17 and the forward PE ratio is null. Apollo Endosurgery's PEG ratio is -0.52.

    PE Ratio

    n/a
    		 -10.17

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 5.27

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 12.43

    P/FCF Ratio

    n/a
    		 -11.92

    PEG Ratio

    n/a
    		 -0.52
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Apollo Endosurgery.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.35, with a Debt / Equity ratio of 1.75.

    Current Ratio

    n/a
    		 2.35

    Quick Ratio

    n/a
    		 1.89

    Debt / Equity

    n/a
    		 1.75

    Debt / EBITDA

    n/a
    		 -1.82

    Debt / FCF

    n/a
    		 -1.68

    Interest Coverage

    n/a
    		 -5.96

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $380,475.25

    Profits Per Employee

    n/a
    		 $-197,222.77

    Employee Count

    n/a
    		 202

    Asset Turnover

    n/a
    		 0.7

    Inventory Turnover

    n/a
    		 1.89

    Taxes

    Income Tax

    n/a
    		 584K

    Effective Tax Rate

    n/a
    		 -1.49%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is 2.32, so Apollo Endosurgery's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.32

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 9.93

    200-Day Moving Average

    n/a
    		 7.59

    Relative Strength Index (RSI)

    n/a
    		 66.04

    Average Volume (20 Days)

    n/a
    		 1,329,953

    Income Statement

    In the last 12 months, Apollo Endosurgery had revenue of 76.86M and earned -39.84M in profits. Earnings per share was -0.98.

    Revenue

    n/a
    		 76.86M

    Gross Profit

    n/a
    		 42.43M

    Operating Income

    n/a
    		 -27.82M

    Net Income

    n/a
    		 -39.84M

    EBITDA

    n/a
    		 -31.42M

    EBIT

    n/a
    		 -34.58M

    Earnings Per Share (EPS)

    n/a
    		 -0.98
    Full Income Statement

    Balance Sheet

    The company has 57M in cash and 57.06M in debt, giving a net cash position of -63K.

    Cash & Cash Equivalents

    n/a
    		 57M

    Total Debt

    n/a
    		 57.06M

    Net Cash

    n/a
    		 -63K

    Retained Earnings

    n/a
    		 -337.29M

    Total Assets

    n/a
    		 110.23M

    Working Capital

    n/a
    		 53.34M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -31.26M and capital expenditures -2.75M, giving a free cash flow of -34.01M.

    Operating Cash Flow

    n/a
    		 -31.26M

    Capital Expenditures

    n/a
    		 -2.75M

    Free Cash Flow

    n/a
    		 -34.01M

    FCF Per Share

    n/a
    		 -0.84
    Full Cash Flow Statement

    Margins

    Gross margin is 55.2%, with operating and profit margins of -36.2% and -51.84%.

    Gross Margin

    n/a
    		 55.2%

    Operating Margin

    n/a
    		 -36.2%

    Pretax Margin

    n/a
    		 -51.08%

    Profit Margin

    n/a
    		 -51.84%

    EBITDA Margin

    n/a
    		 -40.88%

    EBIT Margin

    n/a
    		 -36.2%

    FCF Margin

    n/a
    		 -44.25%

    Dividends & Yields

    APEN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for APEN.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Dec 30, 2016. It was a backward split with a ratio of 2:11.

    Last Split Date

    n/a
    		 Dec 30, 2016

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 2:11

    Scores

    Altman Z-Score

    n/a
    		 0.74

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist